OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...
Developing treatment strategies for an understudied bladder disease
Despite its increasing prevalence, a painful condition called bladder pain syndrome, or interstitial cystitis, remains ...
Ophthalmology Times1d
OKYO Pharma files application for Fast Track designation with the FDA for urcosimod for the treatment of neuropathic corneal pain
Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...
Verywell Health on MSN4d
8 Neuropathy Supplements for Nerve Pain Relief
Damage or injury to nerves causes a painful condition called neuropathy. This article reviews the safety and evidence behind ...
MPR1d
OKYO Pharma Seeks Fast Track for Urcosimod in Neuropathic Corneal Pain
OKYO Pharma has filed a Fast Track designation application with the Food and Drug Administration (FDA) for urcosimod in the treatment of neuropathic ...
Daily Graphic1d
Regenerative medicine: How PRP Therapy is changing treatment for joint pain, neuropathy, and sexual health
This is the promise of Platelet-Rich Plasma (PRP) therapy, a ground-breakingnatural and safe approach that is changing how ...
PharmiWeb1d
CNX Therapeutics Launches MISABRI PR (Pregabalin) Prolonged-Release Tablets for Neuropathic Pain Management in the UK
CNX Therapeutics Limited (“CNX Therapeutics”) today announced the launch of MISABRI PR (Pregabalin) prolonged-release tablets, a once-daily treatment option for adults with peripheral and central ...
American Woman on MSN5d
Chiropractic Treatment of Sciatica, Back Pain, and Neck Pain
Here's how chiropractic treatments can provide lasting pain relief for sciatica, back pain, & neck pain, helping you regain mobility & improve well-being.
Rolling Out2d
These new remedies works better in pain management
Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...
MIRA Pharmaceuticals Announces Approval and Initiation of Phase 1 Clinical Trial for Ketamir-2 in Neuropathic Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the approval and ...
Business Wire5d
Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Trea…
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...